Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa748
E. Metting, A. Baron, N. Chavannes, A. Tran, Sanne van Luenen, C. Jong
{"title":"Evaluation of a pharmacy based personal health record by elderly respiratory patients","authors":"E. Metting, A. Baron, N. Chavannes, A. Tran, Sanne van Luenen, C. Jong","doi":"10.1183/13993003.congress-2019.pa748","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa748","url":null,"abstract":"","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"120 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128047584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa2236
Maxine E. Whelan, Carmelo Velardo, H. Rutter, L. Tarassenko, A. Farmer
Background: Co-morbid anxiety and depression can add to the complexity of chronic obstructive pulmonary disease (COPD). While digital health technologies for people with COPD support monitoring of vital signs (including oxygen saturation and pulse), mood is not routinely monitored even though it could support self-management. Aim: To report adherence to mood self-monitoring and levels of anxiety and depression for people with COPD. Methods: The sElf-management anD support proGrammE (EDGE) was a 12-month randomised controlled trial involving people with COPD. Participants were asked to complete an anxiety (General Anxiety Disorder, GAD) and depression questionnaire (Patient Health Questionnaire, PHQ) every 4 weeks via a tablet computer. Health status (EuroQol 5 Dimensions, EQ5D), respiratory impairment (St George’s Respiratory Questionnaire-COPD, SGRQ-C) and smoking status were recorded. Answering ≥10 of 12 months was adherent and PHQ and GAD scores of ≥5 positive. Results: Of 106 (99%) participants entering mood data, 81 participants were adherent. There were more ex-smokers in the adherent participant pool (n=71 of 81) compared with the non-adherent participants (n=13 of 25); p Conclusions: People with COPD can self-monitor mood over 12 months. With >50% of participants suggesting an elevated risk of both anxiety and depression (associated with a lower health status and higher respiratory impairment), the opportunity to regularly monitor mood in this patient population could offer useful information for comorbidity management.
{"title":"mHealth mood monitoring for people with COPD","authors":"Maxine E. Whelan, Carmelo Velardo, H. Rutter, L. Tarassenko, A. Farmer","doi":"10.1183/13993003.congress-2019.pa2236","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa2236","url":null,"abstract":"Background: Co-morbid anxiety and depression can add to the complexity of chronic obstructive pulmonary disease (COPD). While digital health technologies for people with COPD support monitoring of vital signs (including oxygen saturation and pulse), mood is not routinely monitored even though it could support self-management. Aim: To report adherence to mood self-monitoring and levels of anxiety and depression for people with COPD. Methods: The sElf-management anD support proGrammE (EDGE) was a 12-month randomised controlled trial involving people with COPD. Participants were asked to complete an anxiety (General Anxiety Disorder, GAD) and depression questionnaire (Patient Health Questionnaire, PHQ) every 4 weeks via a tablet computer. Health status (EuroQol 5 Dimensions, EQ5D), respiratory impairment (St George’s Respiratory Questionnaire-COPD, SGRQ-C) and smoking status were recorded. Answering ≥10 of 12 months was adherent and PHQ and GAD scores of ≥5 positive. Results: Of 106 (99%) participants entering mood data, 81 participants were adherent. There were more ex-smokers in the adherent participant pool (n=71 of 81) compared with the non-adherent participants (n=13 of 25); p Conclusions: People with COPD can self-monitor mood over 12 months. With >50% of participants suggesting an elevated risk of both anxiety and depression (associated with a lower health status and higher respiratory impairment), the opportunity to regularly monitor mood in this patient population could offer useful information for comorbidity management.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114534736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa2230
L. Rijssenbeek-Nouwens, Thijs Beerthuizen, J. Snoeck-Stroband, J. Sont
Background: In severe asthma, it has been shown that HACT improves asthma control. However, asthma may worsen after finishing HACT and returning to sea level. We assessed the effectiveness of patient tailored eHealth self-management support in addition to standard care after discharge from HACT. Methods: In a RCT with 1-year follow-up 62 asthmatic adults were randomised to receive either eHealth self-management support (PatientCoach) in addition to standard care (N=33), or standard care only (N=29) after discharge from a 12-week multi-disciplinary rehabilitation program at a high-altitude asthma centre. Endpoints were changes in asthma-related quality of life (QoL: AQLQ, the higher the better) and asthma control (ACQ, the lower the better), both with a minimally important difference of 0.5 points. Results: Asthma-related QoL and asthma control gradually declined over time in the standard care group, whereas there was less decline in the eHealth group. In both endpoints, mixed-model analysis showed a positive effect in favour of eHealth during follow-up (AQLQ difference 0.39 (0.092 to 0.69); P = .01; ACQ difference -0.50 (-0.86 to -0.15); P = .006), which was especially found in patients with uncontrolled asthma at discharge (AQLQ difference 0.59 (0.19 to 0.99); P = .003; ACQ difference -0.73 (-1.18 to -0.28), P = .002). Conclusion: eHealth self-management support was associated with a smaller gradual decline in QoL and asthma control, especially in patients with suboptimal asthma control after discharge from HACT. eHealth support of adults with severe asthma after discharge from HACT seems feasible and effective to maintain quality of life and asthma control.
{"title":"eHealth self-management support after high-altitude climate treatment (HACT) of severe asthma: a randomised controlled trial","authors":"L. Rijssenbeek-Nouwens, Thijs Beerthuizen, J. Snoeck-Stroband, J. Sont","doi":"10.1183/13993003.congress-2019.pa2230","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa2230","url":null,"abstract":"Background: In severe asthma, it has been shown that HACT improves asthma control. However, asthma may worsen after finishing HACT and returning to sea level. We assessed the effectiveness of patient tailored eHealth self-management support in addition to standard care after discharge from HACT. Methods: In a RCT with 1-year follow-up 62 asthmatic adults were randomised to receive either eHealth self-management support (PatientCoach) in addition to standard care (N=33), or standard care only (N=29) after discharge from a 12-week multi-disciplinary rehabilitation program at a high-altitude asthma centre. Endpoints were changes in asthma-related quality of life (QoL: AQLQ, the higher the better) and asthma control (ACQ, the lower the better), both with a minimally important difference of 0.5 points. Results: Asthma-related QoL and asthma control gradually declined over time in the standard care group, whereas there was less decline in the eHealth group. In both endpoints, mixed-model analysis showed a positive effect in favour of eHealth during follow-up (AQLQ difference 0.39 (0.092 to 0.69); P = .01; ACQ difference -0.50 (-0.86 to -0.15); P = .006), which was especially found in patients with uncontrolled asthma at discharge (AQLQ difference 0.59 (0.19 to 0.99); P = .003; ACQ difference -0.73 (-1.18 to -0.28), P = .002). Conclusion: eHealth self-management support was associated with a smaller gradual decline in QoL and asthma control, especially in patients with suboptimal asthma control after discharge from HACT. eHealth support of adults with severe asthma after discharge from HACT seems feasible and effective to maintain quality of life and asthma control.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123539496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa747
George Shaw, Maxine E. Whelan, L. Armitage, A. Farmer
{"title":"Are mobile device applications effective at supporting COPD self-management compared to usual care?","authors":"George Shaw, Maxine E. Whelan, L. Armitage, A. Farmer","doi":"10.1183/13993003.congress-2019.pa747","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa747","url":null,"abstract":"","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121191424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa2231
Tomasz Grzywalski, Marcin Szajek, Honorata Hafke-Dys, A. Bręborowicz, J. Kocinski, Anna Pastusiak, Riccardo Belluzzo
A stethoscope, introduced more than two centuries ago, is still a tool providing potentially valuable information gained during one of the most common examinations. However, the biggest drawback of auscultation is its subjectivity. It depends mainly on the experience and ability of the doctor to perceive and distinguish pathological signals. Many research has shown very low efficiency of doctors in this area. Moreover, most of physicians are aware of this problem and needs supporting device. Therefore we have developed the Artificial Intelligence (AI) algorithms which recognise pathological sounds (wheezes, rhonchi, fine and coarse crackles). Here we present the comparison of the performance of physicians and AI in detection of those sounds. A database of more than 10 000 recordings described by a consilium of specialists (pulmonologists and acousticians) was used for AI learning. Then another set of more than 500 real auscultatory sounds were used to investigate the efficiency of AI in comparison to a group of doctors. The standard F1-score was used for evaluation, because it considers both the precision and the recall. For each phenomena, the results for the AI is higher than for doctors with an average advantage of 8.4 percentage points, reaching even 13,5 p.p. for fine crackles. The results suggest that the implementation of AI can significantly improve the efficiency of auscultation in everyday practice making it more objective, leading to a minimization of errors. The solution is now being tested with a group of hospitals and medical providers and proves its efficiency and usability in everyday practice making this examination faster and more reliable.
{"title":"Respiratory system auscultation using machine learning - a big step towards objectivisation?","authors":"Tomasz Grzywalski, Marcin Szajek, Honorata Hafke-Dys, A. Bręborowicz, J. Kocinski, Anna Pastusiak, Riccardo Belluzzo","doi":"10.1183/13993003.congress-2019.pa2231","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa2231","url":null,"abstract":"A stethoscope, introduced more than two centuries ago, is still a tool providing potentially valuable information gained during one of the most common examinations. However, the biggest drawback of auscultation is its subjectivity. It depends mainly on the experience and ability of the doctor to perceive and distinguish pathological signals. Many research has shown very low efficiency of doctors in this area. Moreover, most of physicians are aware of this problem and needs supporting device. Therefore we have developed the Artificial Intelligence (AI) algorithms which recognise pathological sounds (wheezes, rhonchi, fine and coarse crackles). Here we present the comparison of the performance of physicians and AI in detection of those sounds. A database of more than 10 000 recordings described by a consilium of specialists (pulmonologists and acousticians) was used for AI learning. Then another set of more than 500 real auscultatory sounds were used to investigate the efficiency of AI in comparison to a group of doctors. The standard F1-score was used for evaluation, because it considers both the precision and the recall. For each phenomena, the results for the AI is higher than for doctors with an average advantage of 8.4 percentage points, reaching even 13,5 p.p. for fine crackles. The results suggest that the implementation of AI can significantly improve the efficiency of auscultation in everyday practice making it more objective, leading to a minimization of errors. The solution is now being tested with a group of hospitals and medical providers and proves its efficiency and usability in everyday practice making this examination faster and more reliable.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"39 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129762947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa741
C. I. Oliveira Jácome, R. Almeida, A. Pereira, P. Vieira-Marques, M. Couto, A. Todo Bom, J. Azevedo, P. Leiria Pinto, A. Castro Neves, N. Pinto, F. Todo Bom, Alberto Costa, J. Cardoso, M. Emiliano, R. Gerardo, A. Arrobas, M. Valério, C. Chaves Loureiro, L. Maia Santos, C. Lozoya, A. Mendes, F. Menezes, R. Gomes, J. C. Cidrais Rodrigues, Georgeta Oiveira, N. Santos, R. Câmara, D. Bordalo, J. Ferreira, R. Rodrigues Alves, Rui Silva, C. Alves, A. Carvalho, F. Teixeira, Diana Silva, M. Cálix, C. Lopes, L. Taborda-Barata, J. Almeida Fonseca
{"title":"Validation of app and telephonic versions of the Control of Allergic Rhinitis and Asthma Test (CARAT)","authors":"C. I. Oliveira Jácome, R. Almeida, A. Pereira, P. Vieira-Marques, M. Couto, A. Todo Bom, J. Azevedo, P. Leiria Pinto, A. Castro Neves, N. Pinto, F. Todo Bom, Alberto Costa, J. Cardoso, M. Emiliano, R. Gerardo, A. Arrobas, M. Valério, C. Chaves Loureiro, L. Maia Santos, C. Lozoya, A. Mendes, F. Menezes, R. Gomes, J. C. Cidrais Rodrigues, Georgeta Oiveira, N. Santos, R. Câmara, D. Bordalo, J. Ferreira, R. Rodrigues Alves, Rui Silva, C. Alves, A. Carvalho, F. Teixeira, Diana Silva, M. Cálix, C. Lopes, L. Taborda-Barata, J. Almeida Fonseca","doi":"10.1183/13993003.congress-2019.pa741","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa741","url":null,"abstract":"","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126457924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa736
U. Vaghela, James Moss, M. Partridge, A. Simoni, A. Bush
Asthma control can be optimised by medication compliance, trigger avoidance and recognising when and how to react to worsening control and asthma attacks. Failure to support this, by the under-issuing of personalised asthma action plans (PAAPs) by healthcare professionals (HCPs) and under-utilisation by patients, contributes substantially to asthma deaths (NRAD. RCP 2014;27). Since there is evidence that mobile applications can improve chronic disease health outcomes, we hypothesised PAAP digitalisation can improve current asthma self-management approaches. To assess whether and how a digital PAAP could address barriers to PAAP implementation, we performed focus group discussions with primary (n=3) and secondary (n=5) care doctors and nurses involved in asthma care, and patients (n=5) of variable age (18-65) and disease severity (moderate to poor asthma control over 1 year). Within group coding and categorisation contributed to a cross-case thematic framework for analysis. We found that patients and HCPs experience decision-making uncertainty using current PAAPs. In primary care, there is no uniformity in PAAP usage and methods to evaluate self-management efficacy. A digital PAAP would enable longitudinal data recording with objective monitoring capabilities. Patients valued the interactive, real-time support it could provide in affirming treatment escalation and medication choices. Nevertheless, a digital tool may have adverse effects, with concerns over data overload, quality and overdependence on technology. However, if built using a validated algorithm and in collaboration with key stakeholders, digital PAAPs could optimise self-management assessment and execution for patients and HCPs.
{"title":"Digitalising the personalised asthma action plan (PAAP) - a multi-perspective qualitative study","authors":"U. Vaghela, James Moss, M. Partridge, A. Simoni, A. Bush","doi":"10.1183/13993003.congress-2019.pa736","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa736","url":null,"abstract":"Asthma control can be optimised by medication compliance, trigger avoidance and recognising when and how to react to worsening control and asthma attacks. Failure to support this, by the under-issuing of personalised asthma action plans (PAAPs) by healthcare professionals (HCPs) and under-utilisation by patients, contributes substantially to asthma deaths (NRAD. RCP 2014;27). Since there is evidence that mobile applications can improve chronic disease health outcomes, we hypothesised PAAP digitalisation can improve current asthma self-management approaches. To assess whether and how a digital PAAP could address barriers to PAAP implementation, we performed focus group discussions with primary (n=3) and secondary (n=5) care doctors and nurses involved in asthma care, and patients (n=5) of variable age (18-65) and disease severity (moderate to poor asthma control over 1 year). Within group coding and categorisation contributed to a cross-case thematic framework for analysis. We found that patients and HCPs experience decision-making uncertainty using current PAAPs. In primary care, there is no uniformity in PAAP usage and methods to evaluate self-management efficacy. A digital PAAP would enable longitudinal data recording with objective monitoring capabilities. Patients valued the interactive, real-time support it could provide in affirming treatment escalation and medication choices. Nevertheless, a digital tool may have adverse effects, with concerns over data overload, quality and overdependence on technology. However, if built using a validated algorithm and in collaboration with key stakeholders, digital PAAPs could optimise self-management assessment and execution for patients and HCPs.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131263591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa2232
José Cerdán de las Heras, O. Hilberg, A. Løkke, E. Bendstrup
Background: In Idiopathic Pulmonary Fibrosis (IPF), pulmonary rehabilitation (PR) is recommended to improve quality of life (QoL) and exercise capacity (EC). Not all patients with IPF can participate in hospital based PR due to frailty and long travelling distances. Tele-rehabilitation (TR) might be an alternative solution. We investigated the feasibility and efficacy of TR on EC and QoL in patients with IPF. Method: Single-center, prospective, randomized study, including stable patients with IPF for 3 months (3M) of TR: video and chat-consultations with a real physiotherapist and workout sessions with a virtual autonomous physiotherapist agent (VAPA). Forced vital capacity (FVC), diffusion capacity (DLCO) was registered at baseline (BL). EC evaluated with 6-minute-walk-test distance (6MWTD) and QoL with Kings Brief Interstitial Lung Diseases (KBILD) and St. George’s Respiratory Questionnaire (SGRQ) before and after 3M of training. Control patients did not receive hospital-based PR. Results: 29 patients were included, 15 in the intervention group (IN) (male 86.7%, mean age 69.7±8.7 years, FVC % 76.7±16.4, DLCO % 46.5±11), and 14 in the control group (CO) (male 57.1%, mean age 72±7.6 years, FVC % 90.8±16.5, DLCO % 55±14 ). BL and 3M data can be seen in table. Conclusion: TR with VAPA is feasible for IPF. Improved EC was shown after 3M follow up.
{"title":"Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis","authors":"José Cerdán de las Heras, O. Hilberg, A. Løkke, E. Bendstrup","doi":"10.1183/13993003.congress-2019.pa2232","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa2232","url":null,"abstract":"Background: In Idiopathic Pulmonary Fibrosis (IPF), pulmonary rehabilitation (PR) is recommended to improve quality of life (QoL) and exercise capacity (EC). Not all patients with IPF can participate in hospital based PR due to frailty and long travelling distances. Tele-rehabilitation (TR) might be an alternative solution. We investigated the feasibility and efficacy of TR on EC and QoL in patients with IPF. Method: Single-center, prospective, randomized study, including stable patients with IPF for 3 months (3M) of TR: video and chat-consultations with a real physiotherapist and workout sessions with a virtual autonomous physiotherapist agent (VAPA). Forced vital capacity (FVC), diffusion capacity (DLCO) was registered at baseline (BL). EC evaluated with 6-minute-walk-test distance (6MWTD) and QoL with Kings Brief Interstitial Lung Diseases (KBILD) and St. George’s Respiratory Questionnaire (SGRQ) before and after 3M of training. Control patients did not receive hospital-based PR. Results: 29 patients were included, 15 in the intervention group (IN) (male 86.7%, mean age 69.7±8.7 years, FVC % 76.7±16.4, DLCO % 46.5±11), and 14 in the control group (CO) (male 57.1%, mean age 72±7.6 years, FVC % 90.8±16.5, DLCO % 55±14 ). BL and 3M data can be seen in table. Conclusion: TR with VAPA is feasible for IPF. Improved EC was shown after 3M follow up.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"99 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130136278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa746
S. A. Shah
{"title":"Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study","authors":"S. A. Shah","doi":"10.1183/13993003.congress-2019.pa746","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa746","url":null,"abstract":"","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"240 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132497493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-28DOI: 10.1183/13993003.congress-2019.pa2235
L. Lahousse, Anna Vanoverschelde
Introduction: Despite inhalation medication being the main treatment of asthma/COPD patients, only one third of patients demonstrates a correct inhaler technique. While pharmaceutical care has shown to effectively improve inhaler technique, the integration of the MyPuff app to support continued patient education at home has not been evaluated. Aim: To investigate improvement in inhaler technique by integrating a mHealth app compared to standard information leaflets into pharmaceutical care provided to patients with asthma/COPD. Methods: This 3 month Belgian community pharmacy-based open RCT enrolled adult patients, from March till December 2018, with registered inhaler therapy for asthma/COPD. Randomization was stratified according to the 9 community pharmacies to either receive aid for using the MyPuff-app, or a standard information leaflet to further optimize their inhaler technique at home. Inhaler technique was scored by comparing the patient demonstration with the correct protocol per device. Results: Seventy community patients (median age 64y, 56% females; 44% asthma, 39% COPD, 17% ACO) were randomized to the app (n=37; 53%) or leaflet (n=33; 47%). In 60 patients with follow-up, mean score on inhaler technique improved from 49% (SD 28%) to 65% (SD 33%) and the number of patients making critical errors dropped from 52% to 33%. Patients in the app group did not improve more than in the leaflet group. The reported use of the app (13%) was lower than the leaflet use (57%). Conclusion: The inhaler technique of asthma/COPD patients was improved 3 months after pharmaceutical care delivery, however, providing an app to further optimize inhaler technique at home was not better than providing an information leaflet.
{"title":"Improving inhaler technique in asthma/COPD by mHealth: a Belgian RCT","authors":"L. Lahousse, Anna Vanoverschelde","doi":"10.1183/13993003.congress-2019.pa2235","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa2235","url":null,"abstract":"Introduction: Despite inhalation medication being the main treatment of asthma/COPD patients, only one third of patients demonstrates a correct inhaler technique. While pharmaceutical care has shown to effectively improve inhaler technique, the integration of the MyPuff app to support continued patient education at home has not been evaluated. Aim: To investigate improvement in inhaler technique by integrating a mHealth app compared to standard information leaflets into pharmaceutical care provided to patients with asthma/COPD. Methods: This 3 month Belgian community pharmacy-based open RCT enrolled adult patients, from March till December 2018, with registered inhaler therapy for asthma/COPD. Randomization was stratified according to the 9 community pharmacies to either receive aid for using the MyPuff-app, or a standard information leaflet to further optimize their inhaler technique at home. Inhaler technique was scored by comparing the patient demonstration with the correct protocol per device. Results: Seventy community patients (median age 64y, 56% females; 44% asthma, 39% COPD, 17% ACO) were randomized to the app (n=37; 53%) or leaflet (n=33; 47%). In 60 patients with follow-up, mean score on inhaler technique improved from 49% (SD 28%) to 65% (SD 33%) and the number of patients making critical errors dropped from 52% to 33%. Patients in the app group did not improve more than in the leaflet group. The reported use of the app (13%) was lower than the leaflet use (57%). Conclusion: The inhaler technique of asthma/COPD patients was improved 3 months after pharmaceutical care delivery, however, providing an app to further optimize inhaler technique at home was not better than providing an information leaflet.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127306231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：